Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) announced its financial results Friday for the first quarter ended June 30, 2024. The Canadian cannabis giant reported a record quarter for Canadian medical marijuana, with new revenue surging 20% year-over-year and representing the 6th consecutive quarter of growth. In addition, the company has been ramping up its efforts to expand in the U.S. market via the Canopy USA business unit. See Also: Canopy Growth Doubles Down On Its USA Strategy, Announces Exercise of Acreage Options “The fundamentals of our business continue to strengthen, and our focus on profitable revenue generation is yielding clear results as we set the stage for growth in the second half of fiscal ...